JDRF is the charity of choice for the Noosa Classic
Following a hugely successful first year- where over 1,200 riders took part in the Sunday ride- the Noosa Classic is back on August 18, 2019! Join the road cycling gran fondo set in one of Australia’s most beautiful beachside locations.
With three course lengths available, there’s sure to be a route to satisfy all tastes, abilities and fitness levels. For the more hardcore (and brave) riders out there, you can take on the 160km Maxi Classic. If you have more modest sights but still want to test yourself, the 120km Challenge Classic could well be for you. And for those wanting a more leisurely roll around the Noosa hinterland, then the 45km Social Classic is sure to keep you (and the lungs and legs!) very happy indeed.
What’s more, the Noosa Classic offers riders the chance to do some good and contribute to the worthy cause of their choice. With the “You Decide, You Choose” fundraising approach, there are no limitations on the charity each participant can raise money for, adding to the $300,000 already raised across the previous six Classic events.
The Noosa Classic will surely be a bike ride to remember, but also a classic Australian experience, and a sensual feast of visual and gourmet delights, and a great opportunity to raise money for a charity close to your heart. So, gather your cycling mates, get yourselves ready, and mark Sunday 18 August 2019 down on your calendar.
As an added incentive, register before Sunday March 24 to receive a free event jersey worth $115!
Register & start fundraising today: www.noosaclassic.com.au
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]